Precision BioSciences, Inc. (DTIL)
7.78
-0.62
(-7.38%)
USD |
NASDAQ |
Aug 28, 16:00
7.80
+0.02
(+0.26%)
Pre-Market: 20:00
Precision BioSciences Shareholders Equity (Quarterly) : 45.29M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.29M |
| March 31, 2026 | 76.10M |
| December 31, 2025 | 92.25M |
| September 30, 2025 | 16.63M |
| June 30, 2025 | 34.05M |
| March 31, 2025 | 49.34M |
| December 31, 2024 | 56.39M |
| September 30, 2024 | 64.87M |
| June 30, 2024 | 74.71M |
| March 31, 2024 | 37.21M |
| December 31, 2023 | 18.86M |
| September 30, 2023 | 29.06M |
| June 30, 2023 | 34.04M |
| March 31, 2023 | 40.18M |
| December 31, 2022 | 60.43M |
| September 30, 2022 | 84.38M |
| June 30, 2022 | 103.02M |
| March 31, 2022 | 69.66M |
| Date | Value |
|---|---|
| December 31, 2021 | 91.17M |
| September 30, 2021 | 101.44M |
| June 30, 2021 | 100.55M |
| March 31, 2021 | 58.82M |
| December 31, 2020 | 44.42M |
| September 30, 2020 | 63.82M |
| June 30, 2020 | 85.60M |
| March 31, 2020 | 115.03M |
| December 31, 2019 | 138.31M |
| September 30, 2019 | 155.79M |
| June 30, 2019 | 173.98M |
| March 31, 2019 | 10.83M |
| December 31, 2018 | 39.96M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -26.37M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 11.69B |
| 4D Molecular Therapeutics, Inc. | 407.66M |
| Agenus, Inc. | -199.08M |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.92M |
| Total Liabilities (Quarterly) | 80.63M |
| Debt to Equity Ratio | 0.6204 |
| Current Ratio | 12.82 |
| Net Debt Paydown Yield | 0.16% |